Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | ADK | P55263 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL81650 | 0.78 | NISCH (0.59) | NISCHMTORADKPDE4APDE4B | |
| Hydrochloric Acid SCHEMBL1536214 | 0.75 | NISCH (0.56) | NISCHMTORADKPDE4APDE4B | |
| SCHEMBL28425230 | 0.75 | NISCH (0.56) | NISCHMTORADKPDE4APDE4B | |
| SCHEMBL101638 | 0.75 | — | — | |
| SCHEMBL22206279 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL238233 | 0.72 | — | — | |
| SCHEMBL6649382 | 0.72 | — | — | |
| SCHEMBL216707 | 0.70 | — | — | |
| SCHEMBL13977589 | 0.69 | NISCH (0.50) | NISCHMTORADKPDE4APDE4B | |
| SCHEMBL1554361 | 0.68 | KDM4E (0.31) | KDM4ESMN1; SMN2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117613506-A | Composite glass fiber diaphragm and preparation method thereof | 陕西科技大学 | 2024-02-27 | — | — | CN | claimed |
| CN-110562976-A | High-efficiency electrocatalytic material and preparation method thereof | 深圳大学 | 2019-12-13 | — | — | CN | claimed |
| US-20170216248-A1 | Enhanced Erythropoiesis and Iron Metabolism | FIBROGEN, INC. | 2017-08-03 | — | — | US | claimed |
| US-9217062-B2 | C-substituted, 1H-azoles for amphoteric, solvent-less proton conductivity | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-12-22 | — | — | US | claimed |
| US-20140039132-A1 | C-SUBSTITUTED, 1H-AZOLES FOR AMPHOTERIC, SOLVENT-LESS PROTON CONDUCTIVITY | RICKS-LASKOSKI HOLLY L (US) | 2014-02-06 | — | — | US | claimed |
| EP-2024385-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-02-18 | — | — | EP | claimed |
| WO-2007141389-A1 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2007-12-13 | — | — | WO | claimed |
| EP-1140822-A1 | STABLE ACTIVATED NOVEL CARBAMIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING UREA | Centre National de la Recherche Scientifique (FR) | 2001-10-10 | — | — | EP | claimed |
| WO-2000042009-A1 | STABLE ACTIVATED NOVEL CARBAMIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING UREA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2000-07-20 | — | — | WO | claimed |
| CN-117613506-A | Composite glass fiber diaphragm and preparation method thereof | 陕西科技大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-110562976-A | High-efficiency electrocatalytic material and preparation method thereof | 深圳大学 | 2019-12-13 | — | — | CN | disclosed |
| CN-110562976-A | High-efficiency electrocatalytic material and preparation method thereof | 深圳大学 | 2019-12-13 | — | — | CN | disclosed |
| US-10428081-B2 | EGFR inhibitor, preparation method and use thereof | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2019-10-01 | — | — | US | disclosed |
| US-20190100528-A1 | EGFR INHIBITOR, PREPARATION METHOD AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2019-04-04 | — | — | US | disclosed |
| WO-2004104005-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2004-12-02 | — | — | WO | disclosed |
| US-5834176-A | Silver halide photographic light-sensitive material | KONICA CORPORATION (JP) | 1998-11-10 | — | — | US | disclosed |
| EP-0752614-A2 | Silver halide photographic light-sensitive material | KONICA CORPORATION (JP) | 1997-01-08 | — | — | EP | disclosed |
| EP-0188400-A2 | Oligopeptides, intermediates and process for their preparation | CIBA-GEIGY AG (CH) | 1986-07-23 | — | — | EP | disclosed |
| US-4213986-A | DERIVATIVES CONTAIN TETRAZOLE RING, TREATMENT OF PURINE METABOLIC DISORDER, ANTIURICOPATHIC | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-07-22 | — | — | US | disclosed |
| US-4152440-A | DIURETICS, ANALGESICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170216248-A1 | Enhanced Erythropoiesis and Iron Metabolism | EPOR, TFRC, HAMP | NISCH 3670/4885MTOR 1892/4885ADK 2503/4885 |
| US-20190100528-A1 | EGFR INHIBITOR, PREPARATION METHOD AND USE THEREOF | EGFR, ERBB2, ERBB4 | NISCH 3283/4885MTOR 865/4885ADK 255/4885 |
| US-10428081-B2 | EGFR inhibitor, preparation method and use thereof | EGFR, ERBB2, ERBB4 | NISCH 3283/4885MTOR 865/4885ADK 255/4885 |
| US-20140039132-A1 | C-SUBSTITUTED, 1H-AZOLES FOR AMPHOTERIC, SOLVENT-LESS PROTON CONDUCTIVITY | H1-3, H1-4, HRH3 | NISCH 483/4885MTOR 2629/4885ADK 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.